Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2020
Where the money goes
Where each dollar of revenue went, fiscal 2020
- Research and development64¢$1.8M
- Income tax36¢$987.4K
Out of $12.5K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | $221.6K4 | $32.7K5 | $114.8K6 | $122.7K7 | $12.5K3 |
| Gross profit | |||||
| Research and development | $719.9K4 | $791.1K5 | $474.0K6 | $472.6K7 | $1.8M3 |
| Operating expenses | |||||
| Operating income | -$1.1M4 | -$1.3M5 | -$836.8K6 | -$774.8K7 | -$2.9M3 |
| Interest | |||||
| Income before tax | |||||
| Income tax | -$530.2K5 | $31.9K7 | -$987.4K3 | ||
| Net income | -$1.2M4 | -$539.6K5 | -$1.1M6 | -$793.1K7 | -$1.7M3 |
| Earnings per share | |||||
| Earnings per share (diluted) | |||||
| Shares (weighted, basic) | |||||
| Shares (weighted, diluted) |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Cash | $2.1M5 | $880.2K6 | $131.4K7 | $45.4K7 | $215.8K3 |
| Current assets | $2.2M4 | $1.2M5 | $223.4K6 | $118.2K7 | $277.6K3 |
| Property, plant and equipment | |||||
| Intangible assets | |||||
| Total assets | $6.4M4 | $5.4M5 | $4.4M6 | $4.2M7 | $4.0M3 |
| Current liabilities | $46.1K4 | $10.6K5 | $19.4K7 | $3.2K3 | |
| Long-term debt | $2.2M3 | ||||
| Total liabilities | $1.5M4 | $966.1K5 | $955.4K6 | $1.0M7 | $2.2M3 |
| Retained earnings | |||||
| Shareholders’ equity | $1.8M5 | $1.4M6 | $403.6K7 | -$333.7K3 | -$1.8M11 |
| Shares outstanding | 5.9M shares12 | 5.9M shares4 | 5.9M shares5 | 5.9M shares6 | 5.9M shares7 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What EVOLUTIONARY GENOMICS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $503.7K11 Dec 31, 2022 | $503.7K11 Dec 31, 2021 | 0% |
| Accumulated depreciation | $499.7K11 Dec 31, 2022 | $485.0K11 Dec 31, 2021 | +3.0% |
| Property and equipment, net | $4.0K11 Dec 31, 2022 | $18.7K11 Dec 31, 2021 | −78.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $577.1K11 Dec 31, 2022 | $214.0K11 Dec 31, 2021 | +169.6% |
Intangibles and goodwill
Leadership
Who has led EVOLUTIONARY GENOMICS, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerSteve B. Warnecke Sep 9, 2016 to May 25, 202213
- Chief executive officerMichael Friess Nov 29, 2010 to Nov 29, 201014
- ChairSteve B. Warnecke Sep 9, 2016 to May 25, 202213
- PresidentMichael Friess Nov 29, 2010 to Nov 29, 201014
- Chief financial officerSteve B. Warnecke Jun 16, 2014 to Oct 3, 201415
- Chief financial officerChloe M. Divita Nov 29, 2010 to Nov 29, 201016
Board members and other officers (7)
- Secretary / TreasurerWalter Messier May 25, 2022 to May 25, 202217
- Board memberMark Virgil Boggess Oct 21, 2015 to Oct 29, 201918
- Board memberVirginia P. Orndorff Oct 21, 2015 to May 25, 202219
- Board memberSteve B. Warnecke Jun 16, 2014 to Oct 3, 201415
- Board memberChloe M. Divita Nov 29, 2010 to Nov 29, 201016
- Board memberMichael Friess Nov 29, 2010 to Nov 29, 201014
- Board memberSanford Schwartz Nov 29, 2010 to Nov 29, 201020
Former names
- Fona, Inc.Sep 23, 2010 to Oct 21, 20152
Timeline
Filings
13 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 1 major events, 4 insider forms, 1 private raises, 1 other. The latest 13:
- Apr 28, 202315-12G FORM 15 EDGAR
- Mar 9, 202310-K ANNUAL REPORT EDGAR
- Oct 21, 202210-Q QUARTERLY REPORT EDGAR
- Aug 8, 202210-Q QUARTERLY REPORT EDGAR
- May 25, 20224 EDGAR
- May 25, 20224 EDGAR
- May 25, 20224 EDGAR
- May 16, 202210-Q QUARTERLY REPORT EDGAR
- May 12, 2022D EDGAR
- Mar 31, 20224 OWNERSHIP DOCUMENT EDGAR
- Mar 31, 20228-K CURRENT REPORT EDGAR
- Mar 22, 202210-K ANNUAL REPORT EDGAR
- Nov 1, 202110-Q QUARTERLY REPORT EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Money raised
Private offerings the company reported to the SEC on Form D.
- Mar 24, 2022Raised $1 million in a private offering of equity Form D: 17 investors so far Form D
SEC filer profile
How EVOLUTIONARY GENOMICS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAREVOLUTIONARY GENOMICS, INC.1
- CIK0000884363
- Employer ID (EIN)26-43696981
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)8731 Services-Commercial Physical & Biological Research1
- Business address4220 Morningstar Drive, Castle Rock, CO 801081
- Phone(720) 900-86661
- Shares outstanding6,655,232 as of Mar 1, 202311
- Public float$3.1M as of Jun 30, 202211
- On EDGAR sinceSep 23, 20101
- Filings130 in all: 10-Q (37), 10-K (13), 4 (13), 8-K (9), CORRESP (9), UPLOAD (9), 10-Q/A (6), 3 (6)1
All 23 form types
NT 10-Q (5), 10-K/A (4), D (3), S-4/A (3), 10-12G/A (2), NT 10-K (2), 10-12G (1), 15-12G (1), 424B3 (1), 8-K/A (1), EFFECT (1), S-4 (1), SC 13D (1), SC 13D/A (1), SC 14F1 (1)
- Latest filingsAnnual report (10-K) Mar 9, 2023
Quarterly report (10-Q) Oct 21, 2022
Latest 8-K (8-K) Mar 31, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARMark Virgil Boggess, Board member
- 19SEC EDGARVirginia P. Orndorff, Board member
- 20SEC EDGARSanford Schwartz, Board member
- 21SEC EDGARUnregistered sale of shares